Chronic disease modeling and simulation software

Journal of Biomedical Informatics

Volumn 43, Issue 5, 2010, Pages 791-799

  Barhak, Jacob ^a   Isaman, Deanna J M ^a   Ye, Wen ^a   Lee, Donghee ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Chronic disease; Diabetes; Disease modeling; Markov; Monte Carlo

Indexed keywords

CHRONIC DISEASE; CLINICAL INFORMATION; COMPUTER TOOLS; DECISION MAKERS; DIABETES; DISEASE PROGRESSION; MARKOV; MICHIGAN; MODELING AND SIMULATION; MODELING APPROACH; MODELING CAPABILITIES; MODELING TOOL; MONTE CARLO;

COMPUTER SIMULATION; COMPUTER SOFTWARE; MONTE CARLO METHODS;

DISEASES;

ARTICLE; CHRONIC DISEASE; COMPUTER INTERFACE; COMPUTER MODEL; COMPUTER PROGRAM; DIABETES MELLITUS; DISEASE COURSE; DISEASE MODEL; HIDDEN MARKOV MODEL; INFORMATION PROCESSING; MONTE CARLO METHOD; MORTALITY; PRIORITY JOURNAL; SIMULATION; STROKE; VALIDATION STUDY;

ADULT; CHRONIC DISEASE; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DIABETES MELLITUS; DISEASE PROGRESSION; HUMANS; MALE; MARKOV CHAINS; MEDICAL INFORMATICS; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MONTE CARLO METHOD; SOFTWARE; USER-COMPUTER INTERFACE;

EID: 77956266203     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2010.06.003     Document Type: Article

References (25)

1. Brennan A., Chick S.E., Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ 2006, 15:1295-1310. 10.1002/hec.1148.
2. Weinstein M.C., O'Brien B., Hornberger J., Jackson J., Johannesson M., McCabe C., et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling Studies. Value Health 2004, 6:9-17. American Diabetes Association Consensus Panel 2004), Guidelines for computer modeling of diabetes and its complications (Consensus Statement), Diabetes Care 27 2262-2265.
3. American Diabetes Association Consensus Panel Guidelines for computer modeling of diabetes and its complications (Consensus Statement). Diabetes Care 2004, 27:2262-2265.
4. The Mount Hood 4 Modeling Group Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting. Diabetes Care 2007, 30:1638-1646. 10.2337/dc07-9919.
5. Eddy D.M., Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care 2003, 26(11):3093-3101.
6. Schlessinger L., Eddy D.M. Archimedes: a new model for simulating health care systems: the mathematical formulation. J Biomed Inform 2002, 35:37-50. 10.1016/S1532-046402)00006-0.
7. Eddy D.M., Schlessinger L. Validation of the Archimedes diabetes model. Diabetes Care 2003, 26(11):3102-3110. 10.2337/diacare.26.11.3102.
8. The CDC Diabetes Cost-effectiveness Group Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002, 287(19):2542-2551. 10.1001/jama.287.19.2542.
9. Hoerger TJ, Hicks KA, Bethke AD. A Markov model of disease progression and cost-effectiveness for Type 2 diabetes. Technical Report, RTI health, social, and economics research, funded by centers for disease control and prevention; 2004.
10. Mueller E., Maxion-Bergemann S., Gultyaev D., Walzer S., Freemantle N., Mathieu C., et al. Development and validation of the economic assessment of glycemic control and long-term effects of diabetes (EAGLE) model. Diabetes Technol Ther 2006, 8(2):219-236. 10.1089/dia.2006.8.219.
11. Eagle Diabetes Simulation Model, Version 2.0. Economic assessment of glycemic control and long term effects, Technical Documentation, February 2005, Analytica International GmbH.
12. Brown JB, Russell A, Chan W, Pedula P, Aickin M. The global diabetes model: user friendly version 3.0. Diabetes Research and Clinical Practice Volume 50, (Suppl. 3) (2000) S15-S46. doi: doi:10.1016/S0168-8227(00)00215-1.
13. Clarke P.M., Gray A.M., Briggs A., Farmer A., Fenn P., Stevens R., et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS 68). Diabetologia 2004, 47:1747-1759. 10.1007/s00125-004-1527-z.
14. Herman W.H. Diabetes modeling. Diabetes Care 2003, 26:3182-3183.
15. Zhou H., Isaman D.J.M., Messinger S., Brown M.B., Klein R., Brandle M., et al. A computer simulation model of diabetes progression quality of life and cost. Diabetes Care 2002, 28(12):2856-2863.
16. UK Prospective Diabetes Study UKPDS Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes UKPDS 33. Lancet 1998, 352:837-853. UKPDS. 10.1016/S0140-673698)07019-6.
17. Kothari V., Stevens R.J., Adler A.I., Stratton I.M., Manley S.E., Neil H.A., et al. Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine (UKPDS 60). Stroke 2002, 33:1776-1781. 10.1161/01.STR.0000020091.07144.C7.
18. Isaman D.J.M., Barhak J., Ye W. Indirect estimation of a discrete-state discrete-time model using secondary data analysis of regression data. Stat Med 2009, 28(16):2095-2115. 10.1002/sim.3599.
19. Isaman D.J.M., Herman W.H., Brown M.B. A discrete-state and discrete-time model using indirect estimates. Stat Med 2006, 25:1035-1049. 10.1002/sim.2241.
20. Byrd R.H., Lu P., Nocedal J. A limited memory algorithm for bound constrained optimization. SIAM J Sci Stat Comput 1995, 16(5):1190-1208.
21. Zhu C., Byrd R.H., Nocedal J. L-BFGS-B: algorithm 778: L-BFGS-B FORTRAN routines for large scale bound constrained optimization. ACM Trans Math Software 1997, 23(4):550-560.
22. Diabetes PHD. Online, Accessed on March 25, 2010: Available from: http://www.diabetes.org/living-with-diabetes/complications/diabetes-phd/.
23. Ginsberg J., Mohebbi M.H., Patel R.S., Brammer L., Smolinski M.S., Brilliant L. Detecting influenza epidemics using search engine query data. Nature 2009, 457:1012-1014. 10.1038/nature07634.
24. Weinstein M.C., Coxson P.G., Williams L.W., Pass T.M., Stason W.B., Goldman L. Forecasting coronary heart disease incidence mortality and cost: the Coronary Heart Disease Policy Model. Am J Public Health 1987, 77(11):1417-1426.
25. Urban N., Drescher C., Etzioni R., Colby C. Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening. Control Clin Trials 1997, 18(3):251-270. 96)00233-4. 10.1016/S0197-2456.